Correlation Between ARK Genomic and Invesco Dynamic

Can any of the company-specific risk be diversified away by investing in both ARK Genomic and Invesco Dynamic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ARK Genomic and Invesco Dynamic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ARK Genomic Revolution and Invesco Dynamic Pharmaceuticals, you can compare the effects of market volatilities on ARK Genomic and Invesco Dynamic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ARK Genomic with a short position of Invesco Dynamic. Check out your portfolio center. Please also check ongoing floating volatility patterns of ARK Genomic and Invesco Dynamic.

Diversification Opportunities for ARK Genomic and Invesco Dynamic

0.55

Correlation Coefficient

ARK Genomic  Invesco Dynamic

Very weak diversification

The 3 months correlation between ARK and Invesco is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding ARK Genomic Revolution and Invesco Dynamic Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco Dynamic Phar and ARK Genomic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ARK Genomic Revolution are associated (or correlated) with Invesco Dynamic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco Dynamic Phar has no effect on the direction of ARK Genomic i.e., ARK Genomic and Invesco Dynamic go up and down completely randomly.

Pair Corralation between ARK Genomic and Invesco Dynamic

Given the investment horizon of 90 days ARK Genomic Revolution is expected to generate 3.07 times more return on investment than Invesco Dynamic. However, ARK Genomic is 3.07 times more volatile than Invesco Dynamic Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Invesco Dynamic Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest  2,532  in ARK Genomic Revolution on September 12, 2024 and sell it today you would earn a total of  120.00  from holding ARK Genomic Revolution or generate 4.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

ARK Genomic Revolution  vs.  Invesco Dynamic Pharmaceutical

ARK Genomic Revolution

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ARK Genomic Revolution are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak forward-looking signals, ARK Genomic may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Invesco Dynamic Phar

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Invesco Dynamic Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward-looking indicators, Invesco Dynamic is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with ARK Genomic and Invesco Dynamic

The main advantage of trading using opposite ARK Genomic and Invesco Dynamic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ARK Genomic position performs unexpectedly, Invesco Dynamic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco Dynamic will offset losses from the drop in Invesco Dynamic's long position.

The idea behind ARK Genomic Revolution and Invesco Dynamic Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.